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The P blood group antigen of the GLOB system is a glycolipid 
structure, also known as globoside, on the red blood cells (RBCs) 
of almost all individuals worldwide. The P antigen is intimately 
related to the Pk and NOR antigens discussed in the review 
about the P1PK blood group system. Naturally occurring anti-P 
is present in the serum of individuals with the rare globoside-
deficient phenotypes p, P1k, and P2k and has been implicated in 
hemolytic transfusion reactions as well as unfavorable outcomes 
of pregnancy. The molecular genetic basis of globoside deficiency 
is absence of functional P synthase as a result of mutations 
at the B3GALNT1 locus. Other related glycolipid structures, 
the LKE and PX2 antigens, remain in the GLOB blood group 
collection pending further evidence about the genes and gene 
products responsible for their synthesis. Immunohematology 
2013;29:19–24.
History
Reading the early literature about what are currently 
known as the P1PK and GLOB blood group systems is a bit 
complicated because of evolving name changes based on 
increasing knowledge that has improved previously drawn 
conclusions. The P antigen is also known as globoside, a name 
given because it was discovered and characterized first on red 
blood cells (RBCs) (globule rouge is French for red blood cell). 
The antibody now referred to as anti-P1 was originally called 
anti-P and was initially recognized in 1955 as a component 
of anti-Tja (now designated anti-PP1Pk), the mix of naturally 
occurring antibodies in sera of people with the p phenotype.1 
The first globoside-deficient individual described had the 
rare P1k phenotype and was reported in 1959 by Matson et 
al.2 However, the first paper highlighting the relationship 
between the P1, Pk, and P antigens, as well as determining the 
biochemical structure of these glycolipids, was published by 
Naiki et al.3 15 years later.
Terminology and Nomenclature
The P antigen is so far the only member of the GLOB 
blood group system acknowledged by the International 
Society of Blood Transfusion (ISBT) Working Party for Red 
Cell Immunogenetics and Blood Group Terminology as system 
number 028. The antigen was first assigned to the P blood 
group system (as antigen no. 003002), which is the former 
name of what is now known as the P1PK system (ISBT no. 
003), today housing the P1, Pk, and NOR antigens. Thereafter, 
P was moved to the GLOB blood group collection (ISBT no. 
209, antigen no. 209001) when it was clear that P1 and P 
were only distant relatives. Finally, it was promoted to form 
a blood group system of its own when the molecular genetic 
basis for P antigen synthesis was established in 2002 (antigen 
no. 028001).4 Other names sometimes used instead of P, 
especially in the biochemical and glycobiological literature, 
include globoside, globotetraosylceramide, and Gb4. It should 
be noted that P was the name formerly used for what is now 
known as the P1 antigen. The LKE antigen remains in the 
GLOB collection (ISBT no. 209), together with the newly 
added PX2 antigen.5 The current terminology of the GLOB 
blood group system and collection is summarized in Table 1.
Molecular Genetic Basis of P Antigen
A gene, first cloned in 1998 as a member of the 
3-β-galactosyltransferase family6 but later shown to be a 
3-β-N-acetylgalactosaminyltransferase, was suggested as the 
globoside (Gb4, P) synthase.7 This gene (B3GALNT1, formerly 
known as B3GALT3) is located on the long arm of chromosome 
3 (3q26.1) and has at least five exons with the entire coding 
region in the last exon (Fig. 1). The gene encodes the enzyme 
that synthesizes the P antigen. So far, 12 mutations have been 
found to abolish P synthase activity (Table 2).4,8,9 Only one 
noncritical polymorphism has  been described in the exons of 
this gene, in contrast to the Pk synthase gene (A4GALT), which 
varies more in the population.
Table 1. The GLOB blood group system and collection*
Antigen ISBT system no. ISBT collection no. ISBT antigen no.
P GLOB 028 028001
LKE GLOB 209 209003
PX2 GLOB 209 209004
*209001 and 209002 are obsolete (previously used for P and Pk).
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Antigens and Antibodies in the System
The P antigen is present on RBCs of all individuals except 
ones with the rare phenotypes p, P1k, or P2k. The P1k phenotype 
lacks the P antigen on the cell surface, whereas the P2k phenotype 
lacks both the P and P1 antigens. The p phenotype, on the 
other hand, lacks Pk, P, and P1 antigens. Additional phenotypes 
might exist as Kundu et al. described individuals with either a 
weak P or weak Pk antigen,10,11 but the genetic basis of this is not 
known and such individuals appear to be rare.
The P1k and P2k phenotypes are even rarer than the p 
phenotype but appear to be more common in Japan.12 The 
first individual described with the Pk phenotype was of 
Finnish origin, and it also appears that Finland has a higher 
prevalence of the rare P1k and P2k phenotypes than do other 
populations.13,14
The antigen is well developed at birth13 and is the most 
abundant neutral glycolipid in the RBC membrane with 
approximately 15 × 106 antigens per cell,15 probably the 
highest antigen site density for any blood group antigen. 
None of the enzymes or chemicals used to treat test RBCs for 
antigen modification can abolish its expression, but many, 
including papain and trypsin, markedly enhance it. RBCs 
from P1 individuals express more Pk antigen compared with 
P2 individuals, but the amount of P antigen is similar for both 
phenotypes.15 However, because the Pk antigen constitutes the 
precursor for P synthase, it is possible that the P antigen site 
density is somewhat lower on P2 individuals, but substantial 
interindividual variation exists.
Naturally occurring antibodies of IgM or IgG classes are 
formed when the P antigen is missing. In analogy with ABO 
antibodies, anti-P can cause hemolytic transfusion reactions of 
the acute intravascular type, although no clinically significant 
hemolytic disease of the fetus and newborn has been reported. 
Nevertheless, early spontaneous abortions occur with a higher 
frequency among women with p and P1k or P2k phenotype; this 
is a phenomenon most likely attributable to the IgG component 
of anti-P attacking certain cells in the placenta, where globoside 
Table 2. A summary of all mutations found to date in the B3GALNT1 gene4,8,9
nt. position 202 203 292–293 433 449 456 537–538 598 648 797 811 959
Consensus C G A C A T A T A A G G
ISBT allele name Origin Acc. no.
GLOB*01N.01 Finland T AF494103
GLOB*01N.09 Mahgreb delG FR871173
GLOB*01N.02 Italy insA AY505344
GLOB*01N.03 USA T AY505345
GLOB*01N.12 Turkish G FR871174
GLOB*01N.11 Saudi Arabian G FR871176
GLOB*01N.04 Arabic insA AF494104
GLOB*01N.10 French Caucasian delT* FR871175
GLOB*01N.05 Canada C AY505346
GLOB*01N.06 France C AF494106
GLOB*01N.07 Europe A AF494105
GLOB*01N.08 Switzerland A AY505347
aa position 68 68 98 145 150 152 180 200 216 266 271 320
Consensus R R R R D Y D S R E G W
Change stop fs fs stop G stop fs fs S A R stop
nt = nucleotide, Acc. no. = accession number, aa = amino acid, fs = frameshift. 
*Additional mutation present in allele 376G>A (D126N).
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Fig. 1 The genomic organization of the P (B3GALNT1) gene, not drawn to scale. The numbers in the boxes represent the exon number and 
numbers below boxes represent the number of base pairs in the exon. The black box shows the open reading frame (ORF).
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is highly expressed.16,17 Plasmapheresis to reduce the maternal 
antibody titer has been successfully used in selected cases.18 
Autoanti-P can be formed after viral infections (see Disease 
Associations).
Biochemistry
P antigen belongs to the globoseries of glycolipids. Its 
structure was first elucidated by Naiki et al., and it was later 
shown by Yang et al. that glycolipids are the sole carriers 
of P antigen on RBCs.3,19 The P antigen is made with the 
addition of N-acetylgalactosamine (GalNAc) by a 3-β-N-
acetylgalactosaminyltransferase (β3GalNAc-T1 classified as 
EC 2.4.1.79 but also known as P or Gb4 synthase) using 
Pk (Gb3) as a precursor (Fig. 2). This enzyme is a type II 
transmembrane glycoprotein with 331 amino acids and 
five potential N-glycosylation sites. Similar to other glyco-
syltransferases, it resides in the Golgi apparatus, where it is 
part of the glycosylation machinery of the cell. The crystal 
structure of this enzyme has not yet been solved, and regulation 
of its transcription is not well understood either.
Tissue Distribution
Expression of the P antigen has been studied in several 
species.20–22 Studies of mouse tissues show expression 
patterns similar to those of humans, although there are some 
differences.21
The P antigen is expressed on a number of other cells in 
addition to RBCs, but various studies using different antibodies 
or methods have come to different conclusions about where 
it is expressed. Soluble P substance has also been detected in 
plasma.23,24 Small amounts of Pk, together with higher amounts 
of P, are present on intestinal epithelial cells.25 P antigen 
expression is also seen on megakaryocytes and fibroblasts but 
not on lymphocytes and granulocytes according to von dem 
Borne et al.,26 whereas Shevinsky et al.27 could not detect P 
on fibroblasts. In another study, P was detected in 11 of 16 
investigated tissues, especially those of mesodermal origin.28 
Placenta and fetal heart and kidney are other tissues where P is 
present.17 The P antigen is expressed on embryonal carcinoma 
cells and, according to Song et al.,29 is a possible initiator of 
signal transduction through AP-1 and CREB, associated with 
cell adhesion. High expression of the B3GALNT1 gene has 
been demonstrated in brain and heart, moderate expression in 
lung, placenta, and testis, and low expression in kidney, liver, 
spleen, and stomach.7
Disease Associations
Parvovirus B19, which causes the so-called fifth disease, 
uses erythroid precursor cells expressing high levels of P 
antigen for its replication.30,31 Infection during pregnancy 
with B19 can give rise to fetal anemia and, in some cases, fetal 
loss as a result of inhibition of hematopoiesis.32 Paroxysmal 
cold hemoglobinuria, which can be seen in children after 
a viral infection, can be caused by an autoanti-P. This 
complement-fixing and cold-reactive antibody, also called 
Donath-Landsteiner antibody, lyses autologous P-positive 
erythrocytes.33 P-fimbriated uropathogenic Escherichia 
coli that express Pap-encoded adhesins bind to glycolipid 
structures containing the Gal4Gal motif and can cause 
urinary tract infections such as cystitis and pyelonephritis. 
This includes the P antigen and other globoseries antigens like 
Pk, as well as the neolactoseries P1 antigen.34,35
Related Antigens in the GLOB Collection
The LKE (Luke) Antigen
The Luke (LKE, also known as SSEA-4 or 
monosialogalactosylgloboside, MSGG) antigen was found in 
196536 and named LKE in 1986 after the first patient with 
anti-LKE. Since 1990, LKE belongs to the GLOB collection 
(ISBT no. 209). The antigen, which was given number 209003, 
is formed by sequential addition of a galactose (Gal) moiety 
and thereafter sialic acid (NeuAc) to the P antigen to form 
Fig. 2 Schematic summary of the synthesis of P antigen. The a- or 
β-linkages are shown along with the informative numbers in the 1,3 
or 1,4 glycosidic bonds.
 Glucose (Glc)           Galactose (Gal)
 N-acetylgalactosamine (GalNAc)
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galactosylgloboside (Gb5) and LKE, respectively. Although 
the enzyme responsible for Gb5 synthesis is thought to be 
encoded by B3GALT5, Gb5 is not known to elicit an antibody 
response and is therefore not classified as a blood group 
antigen. On the other hand, anti-LKE is found in LKE-
negative individuals, but the enzyme responsible for synthesis 
of LKE has not yet been identified, which means LKE remains 
in the GLOB collection. Anti-LKE is a rare finding, and no 
clinically significant reactions have been reported. There are 
three different LKE phenotypes: strongly positive (80–90% of 
individuals), weakly positive (10–20%), and negative (1–2%). 
In addition to RBCs, LKE is expressed on endothelial cells, 
smooth muscle cells, kidney cells, platelets, and mesenchymal 
stem cells.37–39 Individuals with the LKE-negative phenotype 
express more Pk antigen compared with individuals with LKE-
positive phenotype.40
The PX2 Antigen
The PX2 antigen, a high-prevalence antigen originally 
designated as the x2 glycolipid, was first mentioned by Kannagi 
et al.,41 and the structure was later characterized further 
by Thorn et al.,42 who also found it elevated on RBCs with 
the p phenotype. It is formed by addition of a β3GalNAc to 
paragloboside, the same precursor used by the FUT1 enzyme 
to make H antigen or P1 synthase to make P1. There are also 
sialylated variants of x2 described.42
In individuals with the P1k phenotype only anti-P is 
expected in plasma according to textbooks, but it was recently 
reported that another naturally occurring antibody specificity 
could give rise to a weak or variable crossmatch reactivity 
with p phenotype RBCs owing to their elevated amounts 
of x2 glycolipid.5 At the same time, all P1k and P2k RBCs 
were compatible. In the absence of a functional β3GalNAc 
transferase because of B3GALNT1 mutations in P1k and P2k 
phenotype individuals, it is hypothesized that paragloboside 
can no longer be extended to form PX2 but this has yet to be 
proved. In the meantime, the PX2 antigen has been assigned 
to the GLOB collection (ISBT no. 209).43
The biochemical and genetic relationship between the 
GLOB system and collection antigens discussed in this review 
is summarized in Figure 3.
Summary
The GLOB blood group system currently consists of only 
one antigen, P, or globoside, but is closely associated with the 
antigens in the P1PK blood group system as well as the GLOB 
collection antigens. The P antigen can act as a receptor for 
various pathogens and anti-P can cause hemolytic transfusion 
reactions, spontaneous recurrent abortions, and autoimmune 
anemia as a result of lysis of erythroid progenitors.
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